Hear best practices for improving outcomes using neoadjuvant, adjuvant & perioperative #immunotherapy approaches for #NSCLC from #LungCancer experts Drs. Patel (Sandip Patel MD), Cascone & Heymach in this new #MedEd video from #TTLC24 bit.ly/48ImRrc

A trio of medical, surgical, and radiation oncologists plan to discuss what we know and how to best move forward with the multi-disciplinary management of early-stage NSCLC. Registration is still open for radiation oncologists, thoracic surgeons, pulmonologists, and pathologists:…

Presented our #NCI #SWOG DART sarcomatoid #lungcancer cohort result at #AACR24 ORR 29% (4/14, ongoing CR and 3 durable PRs) treated with nivo/ipi. SWOG Cancer Research Network AACR The Hope Foundation for Cancer Research Lurie Cancer Center NM Media Relations Northwestern Medicine National Cancer Institute NCI CTEP Clinical Research Razelle Kurzrock, MD Sandip Patel MD

Dr. Sandip Patel MD discusses Trop2 ADCs at #PLCClive24 . Sacituzumab govitecan and datopotamab deruxtecan both with some activity but how do they compare to docetaxel? Datopotamab with a good signal in non-squamous. No clear biomarker yet. MedscapeLIVE

Expert antibody drug conjugate panel at #PLCClive24 tackles topics like resistance, toxicity, combinations, sequencing, biomarkers - so much more to learn about ADCs. Great job by Drs. Benjamin Levy Christine Bestvina Sandip Patel MD Joshua Reuss and Beth Sandy MedscapeLIVE

Phenomenal talk by ⁦Jennifer Guerriero, PhD⁩ on role of myeloid cells in breast cancer for our ⁦UC San Diego Health Moores Cancer Center⁩ Solid Tumor Therapeutics Program Seminar ⁦Judith Varner⁩ ⁦Sara Tolaney⁩ ⁦Dr Sarah Sammons⁩ ⁦Rebecca Shatsky, MD⁩

We congratulate the 2024 Class of Fellows of the AACR Academy. The newest AACR Fellows will be inducted during a special ceremony on Friday, April 5 at #AACR24 . bit.ly/3xiyB5H

Abstract (regular) submission deadline upcoming for WCLC24

Time is Running Out! You are invited to participate in the #WCLC24 by submitting your scientific abstract(s). Deadline is April 5, 2024 @ midnight. Guidelines, abstract types accepted, important dates, FAQs & more information available here: wclc2024.iaslc.org/call-for-abstr… #LCSM #IASLC50

Don’t miss the opportunity to attend and present at IASLC #WCLC24 SanDiegoCounty Dr. Nina Niu Sanford Jeff Ryckman Shankar Siva Ben Slotman Alex Louie MD, PhD Simon Lo Drew Moghanaki 🐕

Abstracts are due this week!

Share your science with us in San Diego

Original Articles:

Blood-Based Test for Colorectal Cancer Screening nej.md/3v0J319

Multitarget Stool DNA Test for Colorectal Cancer nej.md/4abqpSZ

Science Behind the Study: Cell-free DNA for Colorectal Cancer Screening nej.md/43noybx

The discussants reviewed safety data for the antibody-drug conjugate patritumab deruxtecan from the phase 2 HERTHENA-Lung01 trial in EGFR-mutant non-small cell lung cancer. #NSCLC | Helena Yu Sandip Patel MD

cancernetwork.com/view/her3-dxd-…

We enjoyed a visit today from ASCO Leadership Development Program mid-career heme/onc specialists learning about the FDA's role in oncology drug development!

#OCEProjectSocrates

Thanks to @fda for a great joint session on leadership in medicine with ASCO

Grateful to @asco for a wonderful Leadership Development Program and look forward to seeing everyone again at the @asco meeting this summer!

Immense thanks for the extraordinary hosting and for the ongoing, vibrant engagement in both enjoyable activities and leadership training U.S. FDA ASCO staff. Dr. Pazdur’s storytelling was not just enlightening but also profoundly inspiring for leadership. Your efforts are…

Registration is open!

Helena A. Yu, MD, and Sandip P. Patel, MD, discussed the phase 2 HERTHENA-Lung01 trial. The trial evaluated HER3-DXd for patients with EGFR-mutated NSCLC after EGFR TKI therapy and platinum-based chemotherapy. Helena Yu Sandip Patel MD

cancernetwork.com/view/her3-dxd-…

Early Registration is open for #WCLC24 in San Diego, CA! WCLC is the best platform for sharing cutting-edge research, fostering collaboration, & facilitating networking among industry leaders, experts & visionaries worldwide. Register Today and Save! bit.ly/WCLC24Reg #LCSM